TickerFactsScreenerDevelopers

Immunome Inc. (IMNM) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2018: -$25.20M2019: -$35.63M2020: $41.34M2021: $48.19M2022: $16.65M2023: $119.88M2024: $181.16M2025: $634.34M$634.34M
2018Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$634.34M+250.1%
2024$181.16M+51.1%
2023$119.88M+619.9%
2022$16.65M-65.4%
2021$48.19M+16.5%
2020$41.34M+216.0%
2019-$35.63M-41.4%
2018-$25.20M—